← Leaderboards
D Gary Gilliland
Dana-Farber Cancer Institute
$5,135,266
Attributed
$5,135,266
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $11.5M · FY2005–19$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$70,802,404 · 9
By mechanism
P30$52,796,958 · 1
P01$16,034,356 · 6
R01$1,971,090 · 2
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- James D Griffin$8,295,553
- A Thomas Look$30,189,128
- Sandra S Zinkel$4,253,324
- Ralph Scully$19,679,999
- William G Kaelin$28,163,102
Others in their field
Top investigators on “Grant”
- David R. Weir · University Of Michigan At Ann Arbor$373,949,788
- David Heimbrook · Leidos Biomedical Research, Inc.$341,196,902
- Eric S Lander · Whitehead Institute For Biomedical Res$323,181,457
- Jeffrey P Krischer · University Of South Florida$258,583,867
- Lawrence Corey · Fred Hutchinson Cancer Center$253,286,867
- Barton F Haynes · Duke University$243,251,908
Research focus
GrantMemberInstitutionInfection Related CancerHealth EconomicsHealth Services AccessibilityCost EffectiveDiagnosisAfricaComparative EffectivenessDiagnosticBiologyDisciplineCause Of DeathCancer RiskAnticancer ResearchChinaCessation Of LifeCancer BiologyCancer BurdenCancer CareCancer Center Support GrantEpigenomicsGenomics
Grant awards (64)
Cancer Center Support Grant$9,559,285
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$246,630
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$201,108
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$200,000
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$199,999
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$99,972
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$78,024
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$9,559,285
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$246,630
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$225,000
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$199,999
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$78,024
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$33,324
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$9,559,285
P30 · FY2017 · CA · contact PI
Cancer Center Support Grant$249,999
P30 · FY2017 · CA · contact PI
Cancer Center Support Grant$125,000
P30 · FY2017 · CA · contact PI
Cancer Center Support Grant$70,220
P30 · FY2017 · CA · contact PI
Cancer Center Support Grant$58,085
P30 · FY2017 · CA · contact PI
Cancer Center Support Grant$9,561,228
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$749,998
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$500,000
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$249,999
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$209,966
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$125,000
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$78,024
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$60,000
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$9,785,343
P30 · FY2015 · CA · contact PI
Cancer Center Support Grant$249,999
P30 · FY2015 · CA · contact PI
Cancer Center Support Grant$125,000
P30 · FY2015 · CA · contact PI
Cancer Center Support Grant$84,156
P30 · FY2015 · CA · contact PI
Cancer Center Support Grant$28,376
P30 · FY2015 · CA · contact PI
MURINE MODELS OF MYELOID MALIGNANCIES$417,233
P01 · FY2012 · CA · contact PI
ADMINISTRATIVE$89,790
P01 · FY2012 · CA · contact PI
MURINE MODELS OF MYELOID MALIGNANCIES$411,941
P01 · FY2011 · CA · contact PI
ADMINISTRATIVE$90,731
P01 · FY2011 · CA · contact PI
MURINE MODELS OF MYELOID MALIGNANCIES$460,338
P01 · FY2010 · CA · contact PI
ADMINISTRATIVE$45,206
P01 · FY2010 · CA · contact PI
MURINE MODELS OF MYELOID MALIGNANCIES$451,464
P01 · FY2009 · CA · contact PI
ADMINISTRATIVE$44,400
P01 · FY2009 · CA · contact PI
Development of Novel Therapeutic Strategies in Human Leukemias$2,299,041
P01 · FY2008 · CA · contact PI
MURINE MODELS OF MYELOID MALIGNANCIES$438,352
P01 · FY2008 · CA · contact PI
ADMINISTRATIVE$43,199
P01 · FY2008 · CA · contact PI
Novel Therapeutic Strategies in Human Myeloid Leukemias$2,191,623
P01 · FY2006 · CA · contact PI
RUNX1 gene dosage and cooperativity in leukemia$274,510
R01 · FY2006 · CA · contact PI
Novel Therapeutic Strategies in Human Myeloid Leukemias$2,185,917
P01 · FY2005 · CA
RUNX1 gene dosage and cooperativity in leukemia$263,158
R01 · FY2005 · CA
Novel Therapeutic Strategies in Human Myeloid Leukemias$2,128,063
P01 · FY2004 · CA
RUNX1 gene dosage and cooperativity in leukemia$263,918
R01 · FY2004 · CA
Novel Therapeutic Strategies in Human Myeloid Leukemias$2,071,388
P01 · FY2003 · CA
RUNX1 gene dosage and cooperativity in leukemia$281,226
R01 · FY2003 · CA
Novel Therapeutic Strategies in Human Myeloid Leukemias$1,994,148
P01 · FY2002 · CA
RUNX1 gene dosage and cooperativity in leukemia$273,497
R01 · FY2002 · CA
HEMATOPOIETIC TRANSFORMATION BY TYROSINE KINASE FUSIONS$0
P01 · FY2002 · DK
TEL/AML1 FUSION IN PEDIATRIC ACUTE LYMPHOCYTIC LEUKEMIA$0
P01 · FY2002 · CA
MURINE MODELS OF FLT3 MEDIATED LEUKEMIAS$0
P01 · FY2002 · CA
SIGNAL TRANSDUCTION IN HEMATOPOIETIC CELLS MEDIATED BY TYROSINE KINASE FUSIONS$296,752
P01 · FY2001 · DK
GENETIC ANALYSIS OF A FAMILIAL LEUKEMIA SYNDROME$217,170
R01 · FY2001 · CA
TEL/AML1 FUSION IN PEDIATRIC ACUTE LYMPHOCYTIC LEUKEMIA$0
P01 · FY2001 · CA
TYROSINE KINASE FUSION IN HEMATOLOGIC MALIGNANCY$0
P01 · FY2001 · CA
TYROSINE KINASE FUSION IN HEMATOLOGIC MALIGNANCY$226,134
P01 · FY2000 · CA
GENETIC ANALYSIS OF A FAMILIAL LEUKEMIA SYNDROME$210,844
R01 · FY2000 · CA
TEL/AML1 FUSION IN PEDIATRIC ALL$186,767
R01 · FY2000 · CA
SIGNAL TRANSDUCTION IN HEMATOPOIETIC CELLS MEDIATED BY TYROSINE KINASE FUSIONS$148,636
P01 · FY2000 · DK
TEL/AML1 FUSION IN PEDIATRIC ACUTE LYMPHOCYTIC LEUKEMIA$0
P01 · FY2000 · CA